Suppr超能文献

药物配伍化学

Drug incompatibility chemistry.

作者信息

Newton David W

机构信息

Department of Biopharmaceutical Sciences, Bernard J. Dunn School of Pharmacy, Shenandoah University, Winchester, VA 22601, USA.

出版信息

Am J Health Syst Pharm. 2009 Feb 15;66(4):348-57. doi: 10.2146/ajhp080059.

Abstract

PURPOSE

The chemical interactions that cause drug incompatibility in solutions, with emphasis on the acid-base and ionized-nonionized forms of organic, weak, electrolyte drugs, are examined.

SUMMARY

When the dilution or mixing of the salt or ionized forms of organic drugs results in precipitation, the most likely cause is formation of the nonionized drug forms. More than 90% of drugs are organic, weak electrolytes, especially those compounded, manufactured, or reconstituted as injections in predominantly ionized or salt forms. Acid-base reactions are the most common causes of drug incompatibility as precipitation of nonionized drug forms. Precipitation is likely when oppositely charged, organic drug ions that contain aromatic rings are combined in relatively strong concentrations. Salts of polyvalent anions and cations are generally less soluble than salts in which both ions are monovalent or in which one ion is monovalent and its opposite ion is polyvalent. The most clinically important potential precipitates among these ions are dibasic and monohydrogen calcium phosphate.

CONCLUSION

Incompatibility of drug and nutrient injections is clinically hazardous. Knowledge of products' chemical facts, organic acid-base equilibria in relation to ionization and nonionization and aqueous solubility, and ranges of pH and ingredient strength from United States Pharmacopeia monographs and product labeling is the foundation of expertise in drug incompatibility. Precipitation in injectable drug solutions should be suspected, particularly when oppositely charged drug salts are mixed in relatively strong concentrations and when pH values of dilutions create more than 1% of nonionized drug forms.

摘要

目的

研究导致溶液中药物不相容的化学相互作用,重点关注有机、弱电解质药物的酸碱形式和离子化-非离子化形式。

总结

当有机药物的盐或离子化形式稀释或混合导致沉淀时,最可能的原因是形成了非离子化药物形式。超过90%的药物是有机弱电解质,特别是那些以主要离子化或盐形式配制、生产或复溶为注射剂的药物。酸碱反应是药物不相容导致非离子化药物形式沉淀的最常见原因。当含有芳香环的带相反电荷的有机药物离子以相对较高的浓度结合时,可能会发生沉淀。多价阴离子和阳离子的盐通常比离子均为单价或其中一个离子为单价而其相反离子为多价的盐更难溶解。这些离子中临床上最重要的潜在沉淀物是磷酸氢钙二水合物和磷酸氢钙一水合物。

结论

药物与营养注射剂的不相容在临床上具有危险性。了解产品的化学性质、与电离和非电离以及水溶性相关的有机酸-碱平衡,以及美国药典专论和产品标签中的pH值范围和成分强度,是药物不相容专业知识的基础。应怀疑注射用药物溶液中出现沉淀,特别是当带相反电荷的药物盐以相对较高的浓度混合,以及稀释液的pH值产生超过1%的非离子化药物形式时。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验